Baxter International BAX Healthcare Systems & Technologies — Discount rate
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Baxter International in its filing.
Tagged under the XBRL concept bax:ReportingUnitCashFlowPercentageDiscountRate.
The source filing: Baxter International’s 10-K, filed February 12, 2026.
- Filed
- Feb 12, 2026, 4:46 PM EST
- Fiscal year
- FY2025
- Accession
- 0001628280-26-007733
The fair value of the trade name intangible asset was determined using the relief from royalty method. Significant assumptions used in the determination of the fair value of the trade name intangible assets included revenue growth rates, a discount rate and a royalty rate. The relief from royalty model used in the determination of the fair value of our trade name intangible asset during 2025 reflected our most recent revenue projections, a discount rate of 9.0% and a royalty rate of 3.0%. Our trade name intangible asset fair value measurement is classified as Level 3 in the fair value hierarchy because it involves significant unobservable inputs.
Item 8. Financial Statements and Supplementary Data.
FAQ
- What is Baxter International's healthcare systems & technologies — discount rate?
- Baxter International (BAX) reported healthcare systems & technologies — discount rate of 9% in Q4 2025.
- What does healthcare systems & technologies — discount rate mean?
- The discount rate is the interest rate used in discounted cash flow models to determine the present value of future cash flows for asset valuation and impairment testing. It reflects the risk-adjusted cost of capital specific to the segment's operations and market environment. Changes in this rate significantly impact the valuation of long-term assets and goodwill.
Ask your AI about Baxter International's healthcare systems & technologies — discount rate.
Connect your AI assistant and compare it to peers, right in your chat.
